
    
      This study is a retrospective cohort study of CHM eyes and participants which will include
      all eligible participants and eyes with the first documented diagnosis of CHM from July 1st,
      2013 to December 31st, 2019 that meet the study criteria. This study will be conducted using
      data from American Academy of Ophthalmology's (AAO) IRISÂ® Registry which captures CHM
      participant's demographics, clinical characteristics and clinical outcomes from 2013.
    
  